About:
Harbinger Health is developing methods to detect cancer at its earliest stages. Cancer detection often happens after the tumor has progressed making it harder to treat patients. Harbinger’s mission is to generate methods to identify cancer in people before they can be called patients using affordable and available technology. To achieve this, Harbinger is developing proprietary solutions for cancer pre-emption using blood-based tests to identify the biological programs of the earliest forms of cancer. Development of these tests employs artificial intelligence and the latest genetic screening technologies. As blood-based tests are accessible to many, Harbinger hopes it will make cancer screening an easier and more effective process.